Switching to low dose of plasma‐derived factor VIII/vWF concentrates with Confact®‐F as salvage immune tolerance induction in haemophilia A patients with inhibitors: five case reports from Japan

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2516|1351-8216|5|e425-e427

ISSN： 1351-8216

Source： HAEMOPHILIA, Vol.1351-8216, Iss.5, 2015-09, pp. : e425-e427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Switching to low dose of plasma‐derived factor VIII/vWF concentrates with Confact®‐F as salvage immune tolerance induction in haemophilia A patients with inhibitors: five case reports from Japan

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : e425-e427

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prospective, observational study of plasma‐derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registry

By  

HAEMOPHILIA, Vol. 21, Iss. 2, 2015-03 ,pp. : e122-e124

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allergic reaction in a cohort of haemophilia A patients using plasma‐derived factor VIII (FVIII) concentrate is rare and not necessarily triggered by FVIII

By  

HAEMOPHILIA, Vol. 21, Iss. 4, 2015-07 ,pp. : e281-e285

John Wiley & Sons Inc

Access to resources Recommend Favorite

US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors

By  

HAEMOPHILIA, Vol. 1351-8216, Iss. 5, 2015-09 ,pp. : 559-567

John Wiley & Sons Inc

Access to resources Recommend Favorite

US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : 559-567

John Wiley & Sons Inc

Access to resources Recommend Favorite